IHI
iShares U.S. Medical Devices ETF
iShares US Dow Jones Medical Equipment Index seeks investment results that correspond generally to the price and yield performance of the Dow Jones US Select Medical Equipment Index.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 3.1 B
ASSETS UNDER MGMT
40 bp
EXPENSES
Fund Basics
| Inception date | May 01, 2006 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ABBOTT LABORATORIES | 17.3 % |
| INTUITIVE SURGICAL INC | 15.3 % |
| STRYKER CORP | 10.8 % |
| BOSTON SCIENTIFIC CORP | 4.7 % |
| MEDTRONIC PLC | 4.7 % |
| BECTON DICKINSON AND CO | 4.5 % |
| EDWARDS LIFESCIENCES CORP | 4.4 % |
| IDEXX LABORATORIES INC | 4.4 % |
| RESMED INC | 4.4 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 4.3 % |
Constituent Breakdown
| Number of holdings | 47 |
| Herfindahl-Hirschman Index | 806 |
| Wgt avg mkt cap (mns) | $108,437 |
| Large cap (>$10bn) | 90.8% |
| Mid cap ($2-10bn) | 6.7% |
| Small cap (<$2bn) | 2.2% |
| Developed mkts. | 99.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
| UNITED STATES | 91.5 % | |
| IRELAND | 7.6 % | |
| BRITAIN | 0.6 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -3.1% | -5.6% | 2.9% | 5.0% | 1.9% | 12.0% | -- | 10.5% |
| Dividend Yield | 0.0% | 0.3% | 0.4% | 0.5% | 0.4% | 0.4% | -- | 0.4% |
| Total Returns | -3.1% | -5.3% | 3.3% | 5.5% | 2.3% | 12.4% | -- | 10.9% | Ann. Volatility | 15.9% | 18.8% | 16.6% | 16.6% | 18.8% | 19.6% | -- | 19.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.71 | 53% |
| MSCI EAFE | 0.77 | 45% |
| MSCI Emg Mkts | 0.55 | 28% |
Liquidity Measures
| Avg. volume (000) | 2,539 |
| ADV traded (mns) | $134 |
| Turnover | 4.2% |
| Avg. Bid/Ask (% of price) | 0.02% |
Technical Indicators
| 30d moving avg. (EMA) | $56.48 |
| Relative strength (RSI) | 33 |
| MACD/Signal | -1.34/-1.23 |
| Bollinger Bands (Upper/Lower) | $59.40/$52.37 |
| Short interest (% of AUM) | 1.5% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IHI |
Expenses vs. IHI |
ALTAR Score™ vs. IHI |
|---|---|---|---|---|
| XHE | State Street SPDR S&P Health Care Equipment ETF | 38.2% | -5 bp | -0.9% |
| MDEV | First Trust Indxx Medical Devices ETF | 33.3% | +30 bp | +0.3% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 24.8% | 0 bp | +2.3% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 23.9% | +25 bp | -3.8% |
| HEAL | Global X HealthTech ETF | 21.6% | +10 bp | -5.7% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 21.0% | +35 bp | -3.5% |
| FMED | Fidelity Disruptive Medicine ETF | 19.8% | +10 bp | -6.3% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 19.1% | +28 bp | -2.5% |
| FHLC | Fidelity MSCI Health Care Index ETF | 18.6% | -32 bp | +1.0% |
| IYH | iShares U.S. Healthcare ETF | 18.5% | 0 bp | +1.5% |
Risk and Returns: IHI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 3/31/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.0%
ALTAR SCORE™
34th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,196 funds in the US Equity category with an average
ALTAR Score™ of 5.9% and a standard deviation
of 2.1%. IHI's ALTAR Score™ is approximately -0.4 standard
deviations above the category average. This places IHI in the 34th percentile
among funds in the category.
Sell-Side Consensus
$72.14
PRICE TARGET
+37.1%
UPSIDE